Chemopreventive agents induce oxidative stress in cancer cells leading to COX-2 overexpression and COX-2-independent cell death

Carcinogenesis

Volumn 30, Issue 1, 2009, Pages 93-100

  Sun, Yu ^a   Chen, Jie ^a   Rigas, Basil ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ACETYLSALICYLIC ACID; CASPASE; CYCLOOXYGENASE 2; DIPHENYLIODONIUM SALT; NITRIC OXIDE DONOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SULINDAC SULFIDE; TEMPOL; XANTHINE OXIDASE;

ANTIOXIDANT ACTIVITY; ARTICLE; CANCER CELL; CANCER PREVENTION; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANTICARCINOGENIC AGENTS; APOPTOSIS; ASPIRIN; BLOTTING, WESTERN; CELL DIVISION; CELL LINE, TUMOR; CYCLOOXYGENASE 2; DINOPROSTONE; ENZYME INDUCTION; HUMANS; MICROSCOPY, FLUORESCENCE; OXIDATIVE STRESS; RNA, SMALL INTERFERING; STRUCTURE-ACTIVITY RELATIONSHIP; SULINDAC;

EID: 58949094558     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn242     Document Type: Article

References (37)

1. Adachi,M. et al. (2007) Nonsteroidal anti-inflammatory drugs and oxidative stress in cancer cells. Histol. Histopathol., 22, 437-442.
2. Gao,J. et al. (2005) Nitric oxide-donating aspirin induces apoptosis in human colon cancer cells through induction of oxidative stress. Proc. Natl Acad. Sci. USA, 102, 17207-17212.
3. Giardina,C. et al. (1998) Nonsteroidal anti-inflammatory drugs, short-chain fatty acids, and reactive oxygen metabolism in human colorectal cancer cells. Biochim. Biophys. Acta, 1401, 277-288.
4. Ng,Y. et al. (2005) The role of docosahexaenoic acid in mediating mitochondrial membrane lipid oxidation and apoptosis in colonocytes. Carcinogenesis, 26, 1914-1921.
5. Rigas,B. et al. (2008) Induction of oxidative stress as a mechanism of action of chemopreventive agents against cancer. Br. J. Cancer, 98, 1157-1160.
6. Ruegg,C. et al. (2003) Non steroidal anti-inflammatory drugs and COX-2 inhibitors as anti-cancer therapeutics: Hypes, hopes and reality. Ann. Med., 35, 476-487.
7. Saji,S. et al. (2004) Novel sensitizing agents: Potential contribution of COX-2 inhibitor for endocrine therapy of breast cancer. Breast Cancer, 11, 129-133.
8. Lanas,A. et al. (2006) Prevention of anti-inflammatory drug-induced gastrointestinal damage: Benefits and risks of therapeutic strategies. Ann. Med., 38, 415-428.
9. Stewart,G.S. et al. (1999) The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder. Cell, 99, 577-587.
10. Rigas,B. et al. (2005) Cancer prevention: A new era beyond cyclooxygenase-2. J. Pharmacol. Exp. Ther., 314, 1-8.
11. Cha,Y.I. et al. (2007) NSAIDs and cancer prevention: Targets downstream of COX-2. Annu. Rev. Med., 58, 239-252.
12. Ulrich,C.M. et al. (2006) Non-steroidal anti-inflammatory drugs for cancer prevention: Promise, perils and pharmacogenetics. Nat. Rev. Cancer, 6, 130-140.
13. Cervello,M. et al. (2006) Cyclooxygenases in hepatocellular carcinoma. World J. Gastroenterol., 12, 5113-5121.
14. Fujimura,T. et al. (2006) Role of cyclooxygenase-2 in the carcinogenesis of gastrointestinal tract cancers: A review and report of personal experience. World J. Gastroenterol., 12, 1336-1345.
15. Chun,K.S. et al. (2004) Signal transduction pathways regulating cyclooxygenase-2 expression: Potential molecular targets for chemoprevention. Biochem. Pharmacol., 68, 1089-1100.
16. Fecker,L.F. et al. (2007) The role of apoptosis in therapy and prophylaxis of epithelial tumours by nonsteroidal anti-inflammatory drugs (NSAIDs). Br. J. Dermatol., 156 (suppl. 3), 25-33.
17. Giardiello,F.M. (1994) Sulindac and polyp regression. Cancer Metastasis Rev., 13, 279-283.
18. Rigas,B. (2007) The use of nitric oxide-donating nonsteroidal anti-inflammatory drugs in the chemoprevention of colorectal neoplasia. Curr. Opin. Gastroenterol., 23, 55-59.
19. Penning,T.D. et al. (1997) Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol- 1-yl]benze nesulfonamide (SC-58635, celecoxib). J. Med. Chem., 40, 1347-1365.
20. Kashfi,K. et al. (2005) Positional isomerism markedly affects the growth inhibition of colon cancer cells by nitric oxide-donating aspirin in vitro and in vivo. J. Pharmacol. Exp. Ther., 312, 978-988.
21. Williams,J.L. et al. (2001) Nitric oxide-releasing nonsteroidal antiinflammatory drugs (NSAIDs) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDs: Implications for colon cancer chemoprevention. Cancer Res., 61, 3285-3289.
22. Nath,N. et al. (2004) NO-donating aspirin inhibits the growth of leukemic Jurkat cells and modulates beta-catenin expression. Biochem. Biophys. Res. Commun., 326, 93-99.
23. Hoshi,H. et al. (1984) Brain- and liver cell-derived factors are required for growth of human endothelial cells in serum-free culture. Proc. Natl Acad. Sci. USA, 81, 6413-6417.
24. Hanif,R. et al. (1996) Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem. Pharmacol., 52, 237-245.
25. Kashfi,K. et al. (2002) Nitric oxide-donating nonsteroidal anti-inflammatory drugs inhibit the growth of various cultured human cancer cells: Evidence of a tissue type-independent effect. J. Pharmacol. Exp. Ther., 303, 1273-1282.
26. Qiao,L. et al. (1995) Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo. Biochim. Biophys. Acta, 1258, 215-223.
27. Sun,Y. et al. (2002) Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells. Cancer Res., 62 6323-6328.
28. Schor,N.F. et al. (2004) Exploiting oxidative stress and signaling in chemotherapy of resistant neoplasms. Biochemistry (Mosc.), 69, 38-44.
29. Atmaca,G. (2004) Antioxidant effects of sulfur-containing amino acids. Yonsei Med. J., 45, 776-788.
30. Griffith,O.W. et al. (1979) Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). J. Biol. Chem., 254, 7558-7560.
31. Li,Y. et al. (1998) Diphenyleneiodonium, an NAD(P)H oxidase inhibitor, also potently inhibits mitochondrial reactive oxygen species production. Biochem. Biophys. Res. Commun., 253, 295-299.
32. Matsui,T. et al. (2000) Diphenyleneiodonium prevents reactive oxygen species generation, tyrosine phosphorylation, and histamine release in RBL-2H3 mast cells. Biochem. Biophys. Res. Commun., 276, 742-748.
33. Shiff,S.J. et al. (1995) Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J. Clin. Invest., 96, 491-503.
34. Hiraishi,H. et al. (1987) Oxygen metabolite-induced cytotoxicity to cultured rat gastric mucosal cells. Am. J. Physiol., 253, G40-G8.
35. Kashfi,K. et al. (2007) The mechanism of action of nitric oxide-donating aspirin. Biochem. Biophys. Res. Commun., 358, 1096-1101.
36. Burdon,C. et al. (2007) Oxidative stress and the induction of cyclooxygenase enzymes and apoptosis in the murine placenta. Placenta 28, 724-733.
37. Halliwell,B. et al. (2004) Measuring reactive species and oxidative damage in vivo and in cell culture: How should you do it and what do the results mean? Br. J. Pharmacol., 142, 231-255.